Related Articles
Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro
Potent anti-metastatic activity of combretastatin-A4
M410, a combretastatin A4 analogue, disrupts microtubules and inhibits HIF-1α in human breast cancer cells
Combretazet-3 a novel synthetic cis-stable combretastatin A-4-azetidinone hybrid with enhanced stability and therapeutic efficacy in colon cancer
Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo Corrigendum in /10.3892/or.2024.8783